News

Remote diabetes monitor receives approval in the US

A remote glucose monitor that allows parents check the levels of blood sugar of their diabetic child has received regulatory approval for clinical studies in the United States.
The bedside device, developed by Medtronic Inc and called the mySentry Remote Glucose Monitor, allows parents to hear their child sleeping in another room, and will help pick up on severe hypoglycaemic reactions, most of which happen during the night, so they do not have to keep checking on their child’s blood sugar levels. It has an alarm to alert about changes to blood glucose, and provides constant information on glucose trends and the insulin pump.
Medtronic, which produces a range of continuous glucose monitors and insulin pumps, is also one of the companies hoping to develop an artificial pancreas system to help provide doses of insulin automatically. Greg Meeha, general manager of the company’s continuous glucose monitoring arm, commented “This is the first step in what we think is going to be a significant innovation category for diabetes care in the future.”
The company will undertake the trial with 285 patients at a variety of sites in the US, with the aim to have the monitor commercially available within the next two or three years.

To Top